Evaluation of the effect of lidocaine-diclofenac cream in reducing local pai
Phase 3
- Conditions
- Procedural pain.
- Registration Number
- IRCT20180129038549N11
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
All adult patients referred to the emergency department of al-Zahra and Kashani hospitals Need for Central Venous Catheter Insertion
Alert
Stable vital signs
Exclusion Criteria
Visual, mental, or verbal disorders
History of favism, methemoglobin, renal and liver disease
Skin diseases at or around the CVC insertion site
History of drug addiction,
History of analgesic use within 24 hours before the procedur
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The severity of pain. Timepoint: After central venous catheter (CVC) insertion. Method of measurement: Visual Analogue Scale.
- Secondary Outcome Measures
Name Time Method The severity of pain. Timepoint: After lidocaine injection. Method of measurement: Visual Analogue Scale.;Drug side effects such as redness, whitening and skin blemishes. Timepoint: Every 5 minutes until the time of discharge. Method of measurement: Observation.